Skip to main content
Clinical Trials/NCT02594540
NCT02594540
Completed
Not Applicable

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial

Federal University of Health Science of Porto Alegre1 site in 1 country28 target enrollmentDecember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Federal University of Health Science of Porto Alegre
Enrollment
28
Locations
1
Primary Endpoint
Kinetic and kinematic gait analysis
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.

Detailed Description

Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or sham stimulation along 4 weeks. Evaluations will be performed before and after the first session, after the forth and the eighth session.

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
September 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Health Science of Porto Alegre
Responsible Party
Principal Investigator
Principal Investigator

Aline de Souza Pagnussat

PhD

Federal University of Health Science of Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of idiopathic Parkinson's disease based on clinical criteria, dopamine transporter (DaT) scans and/or magnetic resonance imaging;
  • Able to walk 25 feet unassisted or with minimal assistance;
  • Presenting freezing of gait;
  • Aged between 50-85 years;
  • Minimum score of 20 in the Mini Mental State Examination (MMSE);

Exclusion Criteria

  • Secondary musculoskeletal disorder involving the lower limb, as chondral injuries, ligament and ankle sprains which may impede the realization of the gait by pain or motion disability;
  • Peripheral neuropathy;
  • Not attending all the treatment;
  • Absolute contraindications for fMRI (just for fMRI examination);
  • Presence of deep brain stimulation;

Outcomes

Primary Outcomes

Kinetic and kinematic gait analysis

Time Frame: 4 weeks of treatment

Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).

Secondary Outcomes

  • Symptoms of Parkinson's disease progress(4 weeks of treatment)
  • Serum levels of BDNF(4 weeks of treatment)
  • Cytokine and Cortisol Assessment(4 weeks of treatment)
  • Sensorio-motor connectivity(4 weeks of treatment)
  • Risk of falls(4 weeks of treatment)
  • Motor impairment(4 weeks of treatment)
  • Level of depression(4 weeks of treatment)
  • Lymphocyte Proliferation Assessment(4 weeks of treatment)

Study Sites (1)

Loading locations...

Similar Trials